Does the share price pullback present a buying opportunity?
Life science focused investment trust Syncona ( SYNC ) generated an excellent net asset value (NAV) total return of 37.9% for the year to 31 March 2019, building on the previous year’s impressive 18.7% advance. Following a share price drop from April’s 294p high point to 223p, this well-followed fund now trades at a more modest 4% premium to net asset value (NAV). This could interest investors keen to...